8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001299933-12-002670
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading htm_46561.htm…